Table 4.
Diagnostic Test Results for Patient Cohort A (Early Recognition by the Sepsis CDS).a
| Gram-negative pathogens | 68 | (54) |
| Escherichia coli | 24 | (19) |
| Klebsiella | 16 | (13) |
| Pseudomonas | 8 | (6) |
| Otherb | 20 | (16) |
| Gram-positive pathogens | 73 | (58) |
| Enterococcus | 9 | (7) |
| Staphylococcus aureus | 14 | (11) |
| Methicillin-resistant Staphylococcus aureus | 14 | (11) |
| Streptococcus pneumoniae | 3 | (2) |
| Coagulase-negative Staphylococci | 10 | (8) |
| Clostridium difficile | 3 | (2) |
| Otherc | 17 | (14) |
| Fungi | 19 | (15) |
| Candida species | 18 | (14) |
| Aspergillus fumigatus | 1 | (1) |
| Viral pneumonia | 7 | (6) |
Abbreviation: CDS, clinical decision support.
Patients with a microbiology or radiology imaging diagnostic test that was positive or with clinical finding and impression documented, with at least one of the pathogens in the table. Data given as n (%). Multiple responses per patient were possible.
Citrobacter, Enterobacter, Proteus, Acinetobacter, Haemophilus, Prevotella oralis, Lactobacillus sp, and Helicobacter pylori antigent.
Hemolysis, Streptococcus salivarius, Streptococcus sp (Mitis/oralis), Viridans streptococci, Bacteriodes fragilis, Actinomyces sp, and Hafnia alvei. Additional pathogens include parasitic Blastocystis hominis as well as diabetic foot infection being documented.